OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Jerry Colca

2 Projects | 1 Researchers | $873,100 Invested

2010

Metabolic Solutions Development Company

Jerry Colca, PhD

Evaluation of MSDC-0160 in subjects with mild Alzheimer's disease

  • Funding Amount: $773,100
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Status: Closed

2009

Metabolic Solutions Development Company

Jerry Colca, PhD

Evaluation of PPAR-sparing Thiazolidinediones as Potential Treatments of Alzheimer's Disease

  • Funding Amount: $100,000
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed